Bortezomib in Combination with Histone Deacetylase Inhibitor-induced Apoptosis of Malignant Hematologic Cells;
硼替佐米联用组蛋白去乙酰化酶抑制剂诱导血液肿瘤细胞凋亡的效率
Efficacy of Bortezomib Combined Dexamethasone in 24 Patients with Multiple Myeloma;
硼替佐米联合地塞米松治疗24例多发性骨髓瘤的疗效分析
Effect of bortezomib used alone or in combination with arsenic trioxide on HL-60 cell xenograft in nude mice;
硼替佐米或联合三氧化二砷治疗HL-60白血病细胞移植瘤裸鼠的实验研究
Effect of dehydroepiandrosterone sulfate on dizocilpine-induced memory impairment in mice and mechanism;
脱氢表雄酮硫酸酯对地佐环平所致记忆损伤小鼠的作用及机制
Effects of dizocilpine on the release of amino acids and free calcium from ischemic synaptosomes;
地佐环平对缺血突触体氨基酸释放和游离钙的影响(英文)
AIM To explore if the influence of N ω nitro L arginine methyl ester (L NAME, nitric oxide synthase inhibitor), dizocilpine 〔MK 801, N methyl D aspartate (NMDA) receptor antagonist〕 and nifedipine (calcium channel blocker) on the action of morphine is mediated by variation of intracellular calcium concentration ([Ca 2+ ] i).
目的 探讨一氧化氮合酶抑制剂左旋硝基精氨酸甲酯 (L NAME)、N 甲基 D 天冬氨酸 (NMDA)受体拮抗剂地佐环平 (MK 80 1)和钙通道阻滞剂硝苯地平对吗啡作用的影响是否与细胞 [Ca2 + ]i 有关。
Lapatinib in Combination with Bortezomib Inhibits Breast Cancer Cells Growth and the Activity of Bortezomib to Lapatinib-resistant Breast Cancer Cell
拉帕替尼联合硼替佐米抑制乳腺癌细胞生长及硼替佐米对拉帕替尼耐药细胞的活性的研究
The Clinical Observation of Bortezomib Used in Relapsed or Refractory Hematologic Malignancy;
硼替佐米治疗难治性血液恶性肿瘤临床观察
The Curative Effect Observation of Bortezomib Combined with Dexamethasone to Treat Multiple Myeloma;
硼替佐米治疗多发性骨髓瘤的疗效观察
Effect of Bortezomib on Proliferation and Apoptosis of Human Lymphoma Raji Cells
硼替佐米对淋巴瘤Raji细胞增殖及凋亡的影响
A Clinical Observation of Bortezomib to Treat Multiple Myeloma of 18 Patients
硼替佐米治疗18例多发性骨髓瘤的临床观察
Determination of Bortezomib in Its Crude Drug by RP-HPLC
RP-HPLC法测定硼替佐米原料药中主药的含量
Effects of bortezomib plus VAD in treatment of multiple myeloma
硼替佐米联合VAD方案治疗多发性骨髓瘤
Apoptosis of Burkitt's Lymphoma Raji Cell Line Induced by Bortezomib
硼替佐米诱导Burkitt淋巴瘤Raji细胞凋亡的研究
Progress of Bortezomib in the Treatmen of Myeloma Bone Disease
硼替佐米治疗骨髓瘤性骨病的研究进展
Bortezomib plus chemotherapy for the treatment of newly diagnosed patients with multiple myeloma
硼替佐米治疗新诊断多发性骨髓瘤的临床观察
Effects of bortezomib on the proliferation,apoptosis and adhesive ability of HCT8 cells
硼替佐米对HCT8细胞增殖、凋亡及黏附能力的影响
Treatment of Newly Diagnosed Multiple Myeloma Based on Bortezomib Plus Dexamethasone;
硼替佐米联合地塞米松治疗初发的多发性骨髓瘤的疗效评价
Bortezomib Combined with Dexamethasone to Treat Multiple Myeloma
硼替佐米联合地塞米松治疗多发性骨髓瘤的疗效观察
The Curative Effect Observation of Bortezomib Combination with Dexamethasone in 35 Patients with Multiple Myeloma
硼替佐米联合大剂量地塞米松治疗多发性骨髓瘤35例疗效观察
Clinical experience and prognostic factors with bortezomib combined regimen in 40 patients with multiple myeloma
硼替佐米联合地塞米松治疗多发性骨髓瘤疗效及影响因素分析
Bortezomib in combination with dexamethasone for the treatment of stage-Ⅲ multiple myeloma
硼替佐米联合地塞米松治疗Ⅲ期多发性骨髓瘤临床观察
Bortezomib combined with dexamethasone for newly diagnosed multiple myeloma
硼替佐米联合地塞米松治疗初诊多发性骨髓瘤的初步观察
Clinical Study on Bortezomib and Thalidomide in the Treatment of Multiple Myeloma;
硼替佐米和沙利度胺治疗多发性骨髓瘤的临床研究